Cargando…
Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries
Resistance to antiretroviral drugs used to treat HIV is an important and evolving concern, particularly in low- and middle-income countries (LMICs) which have been impacted to the greatest extent by the HIV pandemic. Efforts to monitor the emergence and transmission of resistance over the past decad...
Autores principales: | Parkin, Neil, Harrigan, P. Richard, Inzaule, Seth, Bertagnolio, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584185/ https://www.ncbi.nlm.nih.gov/pubmed/37851634 http://dx.doi.org/10.1371/journal.pgph.0001948 |
Ejemplares similares
-
HIV drug resistance surveillance in low- and middle-income countries: 2004 to 2010
por: Bertagnolio, S, et al.
Publicado: (2012) -
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
por: Gupta, Ravindra K, et al.
Publicado: (2018) -
Current Status and the Future of Occupational Safety and Health Legislation in Low- and Middle-Income Countries
por: Ncube, France, et al.
Publicado: (2018) -
Tackling Non-Communicable Diseases In Low- and Middle-Income Countries: Is the Evidence from High-Income Countries All We Need?
por: Ebrahim, Shah, et al.
Publicado: (2013) -
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
por: Rasheed, Huma, et al.
Publicado: (2018)